Curis (CRIS) Other financing activities (2014 - 2023)
Curis' (CRIS) quarterly Other financing activities came in at $178000.0 in Q2 2023, up 19.46% YoY from $149000.0 in Q2 2022, and up 2442.86% on a QoQ basis from $7000.0 in Q1 2023.
Curis (CRIS) Other financing activities (2014 - 2023) Analysis & Trends
Curis (CRIS) has 10 years of Other financing activities data on file, last reported at $178000.0 in Q2 2023.
- Quarterly Other financing activities rose 19.46% year-over-year to $178000.0 in Q2 2023, while the trailing twelve-month figure through Sep 2023 was $284000.0 (up 22.41% YoY) and the FY2022 annual result came in at $248000.0, down 17.33% from the prior year.
- Other financing activities rose to $178000.0 in Q2 2023, from $7000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $169.6 million in Q4 2020 to a low of $7000.0 in Q1 2023.
- A 5-year average of $17.1 million and a median of $99000.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2020 — Other financing activities soared 652207.69% — and 2021, when it plunged 99.95%.
- Tracing CRIS's Other financing activities over 5 years: stood at $26000.0 in 2019, then soared by 652207.69% to $169.6 million in 2020, then sank by 99.95% to $83000.0 in 2021, then climbed by 19.28% to $99000.0 in 2022, then surged by 79.8% to $178000.0 in 2023.
- The last three Other financing activities figures came in at $178000.0 (Q2 2023), $7000.0 (Q1 2023), and $99000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 178,000.00 |
| Jun 30, 2023 | 178,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 99,000.00 |
| Dec 31, 2022 | 99,000.00 |
| Jun 30, 2022 | 149,000.00 |
| Jun 30, 2022 | 149,000.00 |
| Dec 31, 2021 | 83,000.00 |
| Dec 31, 2021 | 83,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Jun 30, 2021 | 116,000.00 |
| Jun 30, 2021 | 116,000.00 |
| Mar 31, 2021 | 79,000.00 |
| Mar 31, 2021 | 79,000.00 |
| Dec 31, 2020 | 169.60 Mn |
| Dec 31, 2020 | 169.60 Mn |
| Jun 30, 2020 | 17.50 Mn |
| Jun 30, 2020 | 17.50 Mn |